Results 141 to 150 of about 1,942 (152)

The association between CYP46A1 rs4900442 polymorphism and the risk of Alzheimer’s disease: A meta-analysis

Neuroscience Letters, 2016
Junxia Xie, Xixun Du
exaly  

NPC1 enables cholesterol mobilization during long‐term potentiation that can be restored in Niemann–Pick disease type C by CYP46A1 activation

EMBO Reports, 2019
Daniel N Mitroi, José A Esteban, Toshihide Kobayashi   +2 more
exaly  

CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer’s Disease

Molecular Neurobiology, 2018
Yu-Hui Liu, Hua-Dong Zhou, Yan-Jiang Wang   +2 more
exaly  

Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription.

Journal of Neurochemistry, 2010
Maria João Nunes, Maria João Gama, Marc Diederich   +2 more
exaly  

Top bar navigation

Frontiers in Molecular Neuroscience, 2020
Silke Miller, Yukitoshi Izumi, Charles F Zorumski   +2 more
exaly  

CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer’s disease

Journal of Neurology, 2012
Hua-Dong Zhou, Yan-Jiang Wang, Gongbo Li
exaly  

In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina

Biochemical and Biophysical Research Communications, 2014
Niyazi ACAR, Lionel Bretillon, Alain Bron   +2 more
exaly  

Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer’s disease

Human Genetics, 2004
Boris Lenhard, Lars Feuk, Niels Andreasen   +2 more
exaly  

Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study

International Journal of Geriatric Psychiatry, 2009
Suk Ling Ma, Nelson Tang, Linda Chiu Wa Lam   +2 more
exaly  

CYP46A1 intron-2T/C polymorphism and Alzheimer's disease: An updated meta-analysis of 16 studies including 3960 cases and 3828 controls

Neuroscience Letters, 2013
exaly